Clinical Trials Browser

Phase 3 × Carcinoma, Basal Cell × BF-200 ALA × Clear all

NCT02144077 2022-11-03

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

Phase 3 Completed

281 enrolled 16 charts

Carcinoma, Basal Cell